Ratings Arjo AB

Equities

ARJO B

SE0010468116

Market Closed - Nasdaq Stockholm 11:29:47 2024-05-21 am EDT 5-day change 1st Jan Change
47.58 SEK -0.13% Intraday chart for Arjo AB -3.88% +20.76%

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
+20.76% 1.21B
B
-6.46% 180B
C+
+3.39% 112B
C
-3.68% 68.53B
A
+5.44% 51.97B
B-
+5.70% 44.08B
B-
+4.54% 42.23B
B+
+25.42% 32.43B
B
+14.86% 26.39B
A-
-4.29% 24.97B
A-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW